Immunodermatology News

IMIDomics and Bristol Myers Squibb have expanded their partnership to include Sjögren's syndrome and atopic dermatitis in their research and development efforts for inflammatory diseases, the companies announced in a press release.

The annual American Society for Dermatologic Surgery meeting was recently held in Chicago, bringing together a wide variety of clinical knowledge, techniques and news.

Almirall announced its 9-month 2023 financial results, which included a year-on-year net sales increase of 6.4% due to its European sales, according to a company press release.

Treatment with Janus kinase inhibitors may be associated with elevated odds of acne, especially among those with dermatologic conditions, according to a study.

Mounting evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease and dementia, according to a systematic review of published studies.

The Skindex-16, a clinical tool for measuring the skin-related quality of life of patients, showed that patients with autoimmune bullous diseases are greatly impacted by disease flares, according to a study.

Two widely available serum marker blood tests, galactomannan and 1,2-beta-D-glucan, may improve diagnostic sensitivity in cases of invasive fungal infections, according to a study.

Samsung Bioepis Co. Ltd. announced in a press release that the company has entered a commercialization agreement with Sandoz for SB17, a proposed biosimilar to Stelara.

Patients that experience cutaneous immune-related adverse events after immune checkpoint inhibitor treatment are more likely to survive their melanoma diagnosis, according to a study.

While the adoption of immunotherapies and targeted systemic therapies for the treatment of melanoma has increased overall survival in patients, it has also significantly increased health care costs, according to a study.